甲状腺功能异常见于高达三分之一接受生物制剂治疗的患者,约有 2% 到 3% 出现一过性的甲状腺毒症。[7]Ahmadieh H, Salti I. Tyrosine kinase inhibitors induced thyroid dysfunction: a review of its incidence, pathophysiology, clinical relevance, and treatment. Biomed Res Int. 2013;2013:725410.https://www.hindawi.com/journals/bmri/2013/725410/http://www.ncbi.nlm.nih.gov/pubmed/24282820?tool=bestpractice.com[8]Torino F, Barnabei A, Paragliola R, et al. Thyroid dysfunction as an unintended side effect of anticancer drugs. Thyroid. 2013;23:1345-1366.http://www.ncbi.nlm.nih.gov/pubmed/23750887?tool=bestpractice.com